University of Queensland biotech start-up, Spinifex Pharmaceuticals Pty Ltd, has secured A$6.3 million in the final tranche of an A$18.3 million series B round to fund clinical efficacy trials of its innovative neuropathic (nerve) pain therapy.
9 September 2011A Member of
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B